NeoGenomics announces launch of new NeoLAB assays to diagnose ...
It is estimated that more than 600,000 bone marrow biopsies are performed annually in the U.S. to diagnose and monitor patients with various hematologic cancers. However, bone marrow biopsies are a painful and uncomfortable procedure for patients, and ...
News-Medical.net - Thu, 11 Jun 2015 06:00

NeoGenomics Launches Twelve NeoLABâ„¢ "Liquid Biopsy" Tests for ...
PharmiWeb.com (press release) - Thu, 11 Jun 2015 04:03



Immunotherapy in Hematologic Malignancies
Immune checkpoint inhibitors targeted against CTLA-4 and PD-1 have demonstrated promising efficacy across solid tumors and hematological malignancies, with FDA approvals for the treatment of metastatic melanoma and advanced lung cancer.
OncLive - Wed, 24 Jun 2015 16:26

NeoGenomics Launches Twelve NeoLABâ„¢ 'Liquid Biopsy' Tests For ...
Giles FJ, Albitar M. Plasma-based testing as a new paradigm for clinical testing in hematologic diseases. Expert Review of Molecular Diagnostics. 2007 Sep;7(5):615-23. Jilani I, Estey E, Manshuri T, Caligiuri M, Keating M, Giles F, Thomas D, Kantarjian ...
Laboratory Network - Fri, 12 Jun 2015 02:56



Higher Graft CD8 Dose Predicts Better Survival in Hematologic Malignancies
Higher graft CD8 dose predicted better survival in patients undergoing reduced-intensity conditioned (RIC) allogenic hematopoietic stem-cell transplantation (alloHSCT) in adults with hematologic malignancies, a new study published online ahead of print ...
Cancer Therapy Advisor - Wed, 10 Jun 2015 08:14

Karyopharm Presents Hematologic Cancer Data on Lead Drug Candidate ...
Over 900 patients have been treated with selinexor in company- and investigator-sponsored Phase 1 and Phase 2 clinical trials in advanced hematologic malignancies and solid tumors. Karyopharm has initiated four registration-directed clinical trials of ...
Nasdaq - Mon, 22 Jun 2015 03:52

Multimodality therapy approaches, local and systemic treatment, compared with ...
Hematologic and non-hematologic toxicities were graded according to Common Terminology Criteria for Adverse Events 4.0. Twenty-one ... The two groups were balanced in terms of patients characteristics and disease status as detailed in Table 2 ...
BMC Blogs Network - Mon, 29 Jun 2015 03:18

Increased risk of nephrolithiasis is associated with treatment of hematologic ...
The incidence of nephrolithiasis in a population of patients (over 1 300 patients with up to 10 years follow-up) with lymphoproliferative and myeloproliferative disorders was 5.5%. In multivariate analysis, we report that diabetes mellitus ...
UroToday - Tue, 16 Jun 2015 11:11

Agreement on the prescription of antimicrobial drugs
Organ dysfunctions were diagnosed based on the following measurements: cardiovascular dysfunction: systolic BP <90 mmHg or mean BP <65 mm Hg or use of vasopressors (noradrenaline, dopamine, epinephrine, vasopressin); hematologic disorders: ...
BMC Blogs Network - Mon, 29 Jun 2015 02:11


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014